Biomatics Capital
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Portal
Select Page

Denali Therapeutics Reports Third Quarter 2019 Financial Results and Business Highlights

by bizlift | Nov 6, 2019 | Denali Press Releases, Portfolio News

Editas Medicine Appoints Judith R. Abrams, M.D., as CMO

by bizlift | Oct 28, 2019 | Editas Press Releases, Portfolio News

BlackThorn Therapeutics Reports New Insights into Neurobehavioral Disorders

by bizlift | Oct 23, 2019 | BlackThorn Press Releases, Portfolio News

Compass Therapeutics Appoints Leading Immuno-Oncology Researchers to its Immuno-Oncology Scientific Advisory Board

by bizlift | Oct 22, 2019 | Compass Press Releases, Portfolio News

BlackThorn Therapeutics Appoints William J. Martin, Ph.D., as CEO to Lead New Stage Growth

by bizlift | Oct 21, 2019 | BlackThorn Press Releases, Portfolio News

Editas Medicine and AskBio Enter Strategic Research Collaboration

by bizlift | Oct 15, 2019 | Editas Press Releases, Portfolio News

« Older Entries
Next Entries »
© Copyright 2025 Biomatics Capital